Florida Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 43 (91% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 55,484
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 69.06%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 18,397
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 70.40%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 27.88% 26.86%
White, Hispanic/Latino Patients 21.04% 23.05%
Black/African American, Non-Hispanic/Latino Patients 31.54% 30.68%
Black/African American, Hispanic/Latino Patients 0.89% 0.88%
Asian Patients3 0.93% 1.04%
American Indian/Alaska Native Patients3 0.69% 0.52%
Native Hawaiian/Other Pacific Islander Patients3 0.24% 0.21%
Patients with More Than One Race3 2.58% 2.58%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 4.32% 4.92%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.53% 1.79%
Unreported/Refused to Report Race and Ethnicity 8.37% 7.48%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 2,383
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 83.78%
COVID-19 Immunization Series Completed 1,906
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 84.80%
COVID-19 Immunization Series Additional 4,336
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 76.80%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 15.02% 13.12% 22.39%
White, Hispanic/Latino Patients 37.35% 33.26% 32.47%
Black/African American, Non-Hispanic/Latino Patients 24.26% 27.39% 29.27%
Black/African American, Hispanic/Latino Patients 1.68% 1.15% 1.06%
Asian Patients3 1.17% 1.36% 3.76%
American Indian/Alaska Native Patients3 0.34% 0.21% 0.67%
Native Hawaiian/Other Pacific Islander Patients3 0.42% 0.16% 0.51%
Patients with More Than One Race3 3.23% 3.67% 3.37%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 9.15% 5.98% 3.04%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.47% 1.47% 1.59%
Unreported/Refused to Report Race and Ethnicity 5.92% 12.22% 1.87%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 25.58%
1 to 24 Hours 13.95%
More Than 24 Hours 58.14%
N/A 2.33%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 2.33%
Staffing to administer the vaccine 34.88%
Vaccine confidence 37.21%
Vaccine storage capacity 0.00%
Vaccine supply 4.65%
Other 9.30%
None 27.91%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 51.16%
Average Percent of Health Center Visits Conducted Virtually 19.30%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 44.19%
Number of Mobile Van Sites 37
Number of Pop-up Clinics 21
Number of School-Based Vaccination Sites 2
Number of Family Vaccination Clinics 23

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 13.95%
Refer patients to another organization that provides monoclonal antibody therapies 37.21%
None 48.84%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 13.95%
Patient awareness/education 4.65%
Staffing capacity 27.91%
Therapy administration/onsite logistics 16.28%
Other 9.30%
None 51.16%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 14
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 124,138

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 71.43%
Provide to General Public Who Came to the Health Center 42.86%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 21.43%
Provide at Other Community Events 42.86%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 14.29%
Other 21.43%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 2
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 100.00%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 0.00%
White, Hispanic/Latino Patients 0.00%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 100.00%
American Indian/Alaska Native Patients3 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 0.00%

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 0.00%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022